GoKawiilPenn researchers use AI to analyze Reddit reports on unapproved retatrutide use
University of Pennsylvania scientists analyzed roughly 150,000 Reddit posts from about 40,000 users to study self-reported effects of retatrutide, an experimental GLP-1 weight-loss drug not yet approved by regulators but obtained by some people in unapproved forms online. The study, published in JAMA Network Open, found that increased appetite was the most commonly reported symptom among classifiable complaints—contrary to the drug's hunger-suppressing design and the digestive issues emphasized in Phase 2 trials.
GoKawiil's interpretation of the reporting above, not reported fact.
The researchers say AI-driven analysis of social media could surface drug-safety patterns that formal clinical trials and monitoring systems might miss, according to senior author Sharath Chandra Guntuku. However, they caution that Reddit users differ substantially from trial participants, so the appetite findings should be treated as a hypothesis to test further rather than confirmed evidence of a new side effect.
- AI analysis of ~150,000 Reddit posts revealed increased appetite as the top reported symptom among unapproved retatrutide users
- This contradicts the drug's intended appetite-suppressing effect and differs from digestive issues flagged in Phase 2 trials
- Researchers caution the findings are hypotheses for further study, not confirmed side effects, due to differences between online users and trial populations
Source: sciencedaily.com, 2026-10-22
Published there as: “People are taking an unapproved weight-loss drug. AI found something surprising”
Read the original report → The summary and analysis above are GoKawiil's own, written from reporting by the source above. Facts and quotes belong to the original publisher.